• Главная
  • NEW DAY MEDICINE
  • 3 (89) 2026
  • 93 -3 (89) 2026 - Tosheva Kh.B., Bakamov D.U. - COMPREHENSIVE ASSESSMENT OF TREATMENT EFFICACY IN POSTMENOPAUSAL PEPTIC ULCER DISEASE THROUGH QUALITY-OF-LIFE INDICATORS

93 -3 (89) 2026 - Tosheva Kh.B., Bakamov D.U. - COMPREHENSIVE ASSESSMENT OF TREATMENT EFFICACY IN POSTMENOPAUSAL PEPTIC ULCER DISEASE THROUGH QUALITY-OF-LIFE INDICATORS

COMPREHENSIVE ASSESSMENT OF TREATMENT EFFICACY IN POSTMENOPAUSAL PEPTIC ULCER DISEASE THROUGH QUALITY-OF-LIFE INDICATORS

Tosheva Kh.B. - Bukhara State Medical Institute named after Abu Ali Ibn Sina

Bakamov D.U. - Bukhara branch of the Republican Scientific Center for Emergency Medical Care Uzbekistan

Resume

120 women were enrolled (fertile, n=53; postmenopausal, subdivided into 2a: eradication only, n=34; and 2b: eradication + HRT, n=33). After 12 weeks, Group 2b significantly outperformed Group 2a across all 8 SF-36 subscales (p<0.001), with a mean total score increase of 17.1 points. Four data visualisation charts demonstrate inter-group differences in symptom frequency, hormone dynamics and quality of life. Findings support mandatory inclusion of HRT in postmenopausal PUD treatment protocols.

Keywords: peptic ulcer disease, postmenopause, quality of life, SF-36, hormone replacement therapy, estradiol, clinical symptoms, treatment efficacy.

First page

570

Last page

576

For citation:Tosheva Kh.B., Bakamov D.U. - COMPREHENSIVE ASSESSMENT OF TREATMENT EFFICACY IN POSTMENOPAUSAL PEPTIC ULCER DISEASE THROUGH QUALITY-OF-LIFE INDICATORS//New Day in Medicine 3(89)2026 570-576 https://newdayworldmedicine.com/en/new_day_medicine/3-89-2026

List of References

  1. Ware J.E., Sherbourne C.D. The MOS 36-item Short-Form Health Survey (SF-36). Med Care. 1992;30(6):473–483.
  2. Амирбеков Б.А. Инструменты оценки качества жизни в гастроэнтерологии: систематический обзор. Терапевтический архив. 2021;93(2):114–120.
  3. Greendale G.A., Karlamangla A.S., Maki P.M. The menopause transition and cognition. JAMA. 2020;323(15):1495–1496.
  4. Radulović P., Čolović R., Ignjatović N. The role of estrogens in gastrointestinal mucosal protection. Eur J Pharmacol. 2018;117:187–188.
  5. Tuo B.G., Jiang H.X., Liu J.Q., Mu C.S. Estradiol and prostaglandin E2 in duodenal mucosal protection. J Physiol. 2011;589(Pt 3):529–539.
  6. Ohno Y., Sone M., Inagaki N. et al. Obesity as a key factor in metabolic comorbidity. J Clin Endocrinol Metab. 2018;103:4456–4464.
  7. Sherwin B.B. Estrogen and cognitive functioning in women: sustained effects after HRT discontinuation. Behav Neurosci. 2012;126(1):123–127.
  8. Dalia A. Mohamed, Hanan A. Rashed. Estrogen and mucosal regeneration: dose-response relationship. Int J Morphol. 2015;52:146–161.
  9. Keshvarzi Z., Keshtkar M., Taghipour A. Estriol and gastrointestinal mucosal regeneration. J Steroid Biochem Mol Biol. 2020;198:105565.
  10. McEwen B.S., Milner T.A. Understanding the broad influence of sex hormones on the brain. J Neurosci Res. 2017;95(1–2):24–39.

    file

    download